
ASH Stock Forecast & Price Target
ASH Analyst Ratings
Bulls say
Ashland Inc is projected to achieve sales growth of 3-6% in the upcoming quarter while maintaining a stable sales forecast for the full year, coupled with an upward adjustment in EBITDA guidance from $460-500 million to $470-500 million. The company is anticipated to improve its leverage ratios significantly, projecting 1.97x in fiscal 2024 and 1.7x in fiscal 2025, alongside an expected margin expansion of 80 basis points in 2024 and 190 basis points in 2025. Additionally, a notable increase in free cash flow to approximately $294 million in the fourth quarter, combined with a capital-light growth strategy, further positions Ashland favorably for higher-margin growth moving forward.
Bears say
The financial performance of Ashland Inc. has shown significant declines across its operating segments, most notably with the Life Sciences segment's EBITDA falling 16% due to weaknesses in Pharma and Nutrition. Furthermore, anticipated seasonal weakness in the second quarter of fiscal 2024 and potential customer destocking at year-end suggest further pressures on revenue and EBITDA, which could be lower year-over-year if demand does not recover. Additionally, the company faced a dramatic 81% decline in the Specialty Additives segment, largely attributed to a downturn in the construction markets, raising concerns about sustained macroeconomic pressure that could adversely affect both volumes and margins moving forward.
This aggregate rating is based on analysts' research of Ashland Global Hlds and is not a guaranteed prediction by Public.com or investment advice.
ASH Analyst Forecast & Price Prediction
Start investing in ASH
Order type
Buy in
Order amount
Est. shares
0 shares